The global care management solutions market was surpassed at USD 11.57 billion in 2022 and is expected to hit around USD 44.58 billion by 2032, growing at a CAGR of 14.44% from 2023 to 2032.
Key Pointers
Report Coverage | Details |
Market Size in 2022 | USD 11.57 billion |
Revenue Forecast by 2032 | USD 44.58 billion |
Growth rate from 2023 to 2032 | CAGR of 14.44% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Companies Covered | Allscripts Healthcare Solutions, Inc.; Epic Systems Corp.; Cognizant; ExlService Holdings, Inc.; Koninklijke Philips N.V.; Cerner Corp.; (Oracle); ZeOmega; Medecision; IBM |
Increasing focus on patient-centric care and the growing burden of healthcare expenditure is boosting the need for integrated health solutions. As a result, they are being used more frequently by healthcare payers, governments, and employer groups. Furthermore, the increasing adoption of technological software and services in the healthcare system is favoring industry growth.As the prevalence of various chronic diseases increases, the need for effective disease management solutions rises.
According to the Centers for Disease Control and Prevention, 90% of USD 4.1 trillion in health expenditure is spent on people with chronic physical and mental health disorders. This rising cost of healthcare possess a huge challenge to the healthcare system. Rising healthcare expenditures have created a strong need to reduce costs while also improving the quality of care. Disease management software can be used to perform risk stratification to access patient care. This helps providers in reducing the overall healthcare cost. Supportive government initiatives boosting the adoption of HCIT solutions to improve patient experience and reduce cost are expected to favor industry growth. Governments insist on value-based care.
The fee-for-services is slowly moving towards value-based care, which is increasing the demand for health management interventions to improve patient engagement and outcomes and deliver results across a wide spectrum of the patient population. Apart from cost reduction and improved efficiency, health management software offers potential advantages in data aggregation. They can aggregate large pools of data, which can be used for predictive analysis. Furthermore, they also help in communication between patients and providers, enabling them to manage multiple patients at one time.
Patients included in care management programs have reduced hospitalizations and ER visits and improved health status and quality of life, as demonstrated by the Alliance of Community Health Plans. The growing adoption of integrated health management services and other digital systems has boosted the launch of new software. For instance, in July 2020, Health Catalyst, Inc., the provider of services and data analytics to healthcare organizations, launched a Care Management Suite, an analytical and patient-centric data-driven method. In April 2022, CareCloud, Inc., introduced a new service for chronic care management. The new services for chronic disease management are part of its rising range of digital health solutions that helps providers in improving patient treatment and revenue streams.
Care Management Solutions Market Segmentations:
By Component | By Mode of Delivery | By End-use |
Services Software |
Web-based Cloud-based On-premise |
Healthcare Providers Healthcare Payers Others |
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Care Management Solutions Market
5.1. COVID-19 Landscape: Care Management Solutions Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Care Management Solutions Market, By Component
8.1. Care Management Solutions Market, by Component, 2023-2032
8.1.1 Services
8.1.1.1. Market Revenue and Forecast (2019-2032)
8.1.2. Software
8.1.2.1. Market Revenue and Forecast (2019-2032)
Chapter 9. Global Care Management Solutions Market, By Mode of Delivery
9.1. Care Management Solutions Market, by Mode of Delivery, 2023-2032
9.1.1. Web-based
9.1.1.1. Market Revenue and Forecast (2019-2032)
9.1.2. Cloud-based
9.1.2.1. Market Revenue and Forecast (2019-2032)
9.1.3. On-premise
9.1.3.1. Market Revenue and Forecast (2019-2032)
Chapter 10. Global Care Management Solutions Market, By End-use
10.1. Care Management Solutions Market, by End-use, 2023-2032
10.1.1. Healthcare Providers
10.1.1.1. Market Revenue and Forecast (2019-2032)
10.1.2. Healthcare Payers
10.1.2.1. Market Revenue and Forecast (2019-2032)
10.1.3. Healthcare Payers
10.1.3.1. Market Revenue and Forecast (2019-2032)
Chapter 11. Global Care Management Solutions Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Component (2019-2032)
11.1.2. Market Revenue and Forecast, by Mode of Delivery (2019-2032)
11.1.3. Market Revenue and Forecast, by End-use (2019-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Component (2019-2032)
11.1.4.2. Market Revenue and Forecast, by Mode of Delivery (2019-2032)
11.1.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Component (2019-2032)
11.1.5.2. Market Revenue and Forecast, by Mode of Delivery (2019-2032)
11.1.5.3. Market Revenue and Forecast, by End-use (2019-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Component (2019-2032)
11.2.2. Market Revenue and Forecast, by Mode of Delivery (2019-2032)
11.2.3. Market Revenue and Forecast, by End-use (2019-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Component (2019-2032)
11.2.4.2. Market Revenue and Forecast, by Mode of Delivery (2019-2032)
11.2.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Component (2019-2032)
11.2.5.2. Market Revenue and Forecast, by Mode of Delivery (2019-2032)
11.2.5.3. Market Revenue and Forecast, by End-use (2019-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Component (2019-2032)
11.2.6.2. Market Revenue and Forecast, by Mode of Delivery (2019-2032)
11.2.6.3. Market Revenue and Forecast, by End-use (2019-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Component (2019-2032)
11.2.7.2. Market Revenue and Forecast, by Mode of Delivery (2019-2032)
11.2.7.3. Market Revenue and Forecast, by End-use (2019-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Component (2019-2032)
11.3.2. Market Revenue and Forecast, by Mode of Delivery (2019-2032)
11.3.3. Market Revenue and Forecast, by End-use (2019-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Component (2019-2032)
11.3.4.2. Market Revenue and Forecast, by Mode of Delivery (2019-2032)
11.3.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Component (2019-2032)
11.3.5.2. Market Revenue and Forecast, by Mode of Delivery (2019-2032)
11.3.5.3. Market Revenue and Forecast, by End-use (2019-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Component (2019-2032)
11.3.6.2. Market Revenue and Forecast, by Mode of Delivery (2019-2032)
11.3.6.3. Market Revenue and Forecast, by End-use (2019-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Component (2019-2032)
11.3.7.2. Market Revenue and Forecast, by Mode of Delivery (2019-2032)
11.3.7.3. Market Revenue and Forecast, by End-use (2019-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Component (2019-2032)
11.4.2. Market Revenue and Forecast, by Mode of Delivery (2019-2032)
11.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Component (2019-2032)
11.4.4.2. Market Revenue and Forecast, by Mode of Delivery (2019-2032)
11.4.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Component (2019-2032)
11.4.5.2. Market Revenue and Forecast, by Mode of Delivery (2019-2032)
11.4.5.3. Market Revenue and Forecast, by End-use (2019-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Component (2019-2032)
11.4.6.2. Market Revenue and Forecast, by Mode of Delivery (2019-2032)
11.4.6.3. Market Revenue and Forecast, by End-use (2019-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Component (2019-2032)
11.4.7.2. Market Revenue and Forecast, by Mode of Delivery (2019-2032)
11.4.7.3. Market Revenue and Forecast, by End-use (2019-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Component (2019-2032)
11.5.2. Market Revenue and Forecast, by Mode of Delivery (2019-2032)
11.5.3. Market Revenue and Forecast, by End-use (2019-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Component (2019-2032)
11.5.4.2. Market Revenue and Forecast, by Mode of Delivery (2019-2032)
11.5.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Component (2019-2032)
11.5.5.2. Market Revenue and Forecast, by Mode of Delivery (2019-2032)
11.5.5.3. Market Revenue and Forecast, by End-use (2019-2032)
Chapter 12. Company Profiles
12.1. Allscripts Healthcare Solutions, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Epic Systems Corp.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Cognizant
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. ExlService Holdings, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Koninklijke Philips N.V
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Cerner Corp.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Oracle
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. ZeOmega
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Medecision
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. IBM
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms